Posted on 2/4/21
Summit Partners Appoints Bob Grady as Advisory Partner
BOSTON & MENLO PARK, Calif. & LONDON--(BUSINESS WIRE)--Summit Partners, a global alternative investment firm, today announced the addition of Bob Grady as Advisory Partner based in . . .
Posted on 2/4/21
Cogito Appoints Mark Leonard as Executive Vice President
Cogito, the leader in AI Coaching Systems for the enterprise, today announced the appointment of Mark Leonard to Executive Vice President of Customer Success.
Posted on 2/4/21
Advent Technologies Combine with AMCI Acquisition Corp.
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Advent Technologies Inc., an innovation-driven company in the fuel cell and hydrogen technology space, and AMCI Acquisition Corp. (NASDAQ: AMCI), a . . .
Posted on 2/4/21
Alexion Reports Fourth Quarter and Full Year 2020 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the fourth quarter and full year of 2020. Total revenues for the full year of 2020 . . .
Posted on 2/4/21
BrightSphere Reports Financial and Operating Results for the Fourth Quarter
BOSTON--(BUSINESS WIRE)--BrightSphere Investment Group Inc. (NYSE: BSIG) today announced its results for the fourth quarter ended December 31, 2020.BrightSphere’s earnings presentation is available at: https://ir.bsig.comAbout BrightSphereBrightSphere is . . .
Posted on 2/4/21
Quanterix Prices Public Offering of Common Stock
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previously announced . . .
Posted on 2/4/21
AcadiaSoft Acquires Quaternion
AcadiaSoft Inc., the leading industry provider of risk and collateral management services for the derivatives community, today announced it has acquired capital markets consulting and software . . .
Posted on 2/4/21
Bridgeline Digital Announces $2.7 Million Registered Direct Offering
WOBURN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based Marketing Technology software, announced today a registered direct offering . . .
Posted on 2/4/21
New Publication Aims to Help Americans Engage in Dialogue About Race
Essential Partners makes decades of expertise in dialogue across differences available to the publicLast year, millions of people around the globe were moved to demonstrate in . . .
Posted on 2/4/21
Biogen Cash Tender Offer for 5.200% Senior Notes
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the commencement of an offer to purchase for cash any and all . . .
Posted on 2/4/21
Biogen Announces Private Exchange Offer for 5.200% Senior Notes
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the commencement of a private offer to exchange any and all of . . .
Posted on 2/4/21
AquaBounty Technologies Prices of $110.5 Million Public Offering of Common Stock
MAYNARD, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced . . .
Posted on 2/4/21
Shawn Tomasello Joins TCR² Therapeutics Board of Directors
TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer
Posted on 2/4/21
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today . . .
Posted on 2/4/21
Xerox Appoints Jacques-Edouard Gueden as President
Xerox Holdings Corporation (NYSE: XRX), a global workplace technology company, announced Jacques-Edouard Gueden as executive vice president and president of Europe, Middle East & Africa
Posted on 2/4/21
Updated: Safest States During COVID-19 – WalletHub Study
With only 2% of the population fully vaccinated against COVID-19 as of February 3, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 2/4/21
Catamaran Bio Appoints Dr. Alvin Shih as CEO
Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat diseases with significant unmet medical need, today announced the appointment of Alvin Shih, . . .
Posted on 2/4/21
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President
BOSTON, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases of . . .
Posted on 2/4/21
U.S. Employment Rate Won't Return to Pre-Pandemic Level Until 2024, Says CBO
Talk about a dire projection.It's no secret that the coronavirus pandemic has battered the U.S. economy. But it could take longer than expected for the situation . . .
Posted on 2/4/21
Daily Stimulus Update: Democrats Forge Forward as Republicans Ask for More Targeted Aid
Democrats are intent on moving forward with stimulus aid -- whether Republicans agree or not.President Joe Biden remains committed to providing meaningful coronavirus relief to the . . .
Posted on 2/4/21
Better Buy: General Electric vs. Boeing
Now that both of these manufacturing giants having released their fourth-quarter earnings reports and offered up their 2021 outlooks, it's an opportune time to sit down . . .
Posted on 2/4/21
How PerkinElmer Beat Expectations in Q4
PerkinElmer (NYSE:PKI) stock skyrocketed 48% in 2020 -- one of its best performances in years. The demand for COVID-19 testing was the primary factor behind that . . .
Posted on 2/4/21
Why Biogen's Q4 Results Were a Bust
You can almost always know how strong a company's near-term prospects are by looking at its stock price. Biogen's (NASDAQ:BIIB) shares sank more than 17% last . . .
Posted on 2/4/21
Rhythm Pharmaceuticals Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 2/4/21
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Boston
